Last reviewed · How we verify
An Open-label Trial of an Erythropoietin Stimulating System to Determine Increased Red Blood Cell Production in Subjects Diagnosed With Anemia of Chronic Disease
The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.
Details
| Lead sponsor | Targeted Medical Pharma |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 30 |
| Start date | 2013-06 |
| Completion | 2013-09 |
Conditions
- Anemia of Chronic Disease
Interventions
- ESS (medical food/drug)
Primary outcomes
- Hemoglogin/Hematocrit — 28 Days
Countries
United States